Attention, dog owners:
Check out this story on USATODAY.com: https://www.usatoday.com/story/money/business/2019/03/26/darwins-natural-pet-products-dog-food-fda-warns-salmonella/3285035002/.
Check out this story on USATODAY.com: https://www.usatoday.com/story/money/business/2019/03/26/darwins-natural-pet-products-dog-food-fda-warns-salmonella/3285035002/France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
FDA warns of 'serious threat to human and animal health' in 3 lots of Darwin's Natural dog foodThe FDA asked consumers on Tuesday to discard three lots of Darwin’s Natural Pet Products dog food due to a Salmonella contamination
Lire la suite »
FDA says cybersecurity vulnerabilities found in some Medtronic devicesThe U.S. Food and Drug Administration (FDA) on Thursday said cybersecurity vulne...
Lire la suite »
Outgoing FDA chief: Altria bait-and-switched me with $12.8 billion Juul investmentFood and Drug Administration (FDA) Commissioner Scott Gottlieb said on Tuesday that tobacco giant Altria went back on its promise to clamp down on vape pods with its $12.8 billion investment in e-cigarette decacorn Juul Labs.
Lire la suite »
Jazz Pharma's sleep disorder treatment gets FDA nodThe U.S. Food and Drug Administration approved Jazz Pharmaceuticals Plc's t...
Lire la suite »
FDA-approved 'breakthrough' heart failure device improves heart function in patients with late-stage diseaseA new device on the market for patients with heart failure is the first device in cardiology to receive a “breakthrough” designation by the Food and Drug Administration.
Lire la suite »
FDA takes up decades-long debate over breast implant safety
Lire la suite »
FDA rejects Sanofi-Lexicon add-on pill for type 1 diabetesThe U.S. Food and Drug Administration declined to approve a drug developed by Sa...
Lire la suite »
FDA Rejects Oral Treatment for Type 1 DiabetesLexicon Pharmaceuticals is developing the treatment, which is called Zynquista, with French pharmaceutical giant Sanofi.
Lire la suite »
FDA approves new device for treating patients with chronic heart failureThe Food and Drug Administration approved a breakthrough medical device last week for patients suffering from chronic, hard-to-treat heart failure.
Lire la suite »